FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071408 [Registered on: 26/07/2024] Trial Registered Prospectively
Last Modified On: 25/07/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Vaccine
Biological 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Better Rabies Shots: Which Method Works Best? 
Scientific Title of Study   Enhancing Rabies Immunity: A Comparative Study of Antibody Responses Post-3rd Vaccine Dose with Different Immunoglobulin Approaches. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  AMANDEV SINGH 
Designation  Assistant Professor 
Affiliation  Government Medical College and Rajindra Hospital Patiala 
Address  New Academic Building, 1st Floor Department of Community Medicine,GMC Patiala Punjab
New Academic Building, 1st Floor Department of Community Medicine,GMC Patiala Punjab
Patiala
PUNJAB
147001
India 
Phone  7837809884  
Fax    
Email  adsingh44rssb@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  AMANDEV SINGH 
Designation  Assistant Professor 
Affiliation  Government Medical College and Rajindra Hospital Patiala 
Address  New Academic Building, 1st Floor Department of Community Medicine,GMC Patiala Punjab
New Academic Building, 1st Floor Department of Community Medicine,GMC Patiala Punjab
Patiala
PUNJAB
147001
India 
Phone  7837809884  
Fax    
Email  adsingh44rssb@gmail.com  
 
Details of Contact Person
Public Query
 
Name  AMANDEV SINGH 
Designation  Assistant Professor 
Affiliation  Government Medical College and Rajindra Hospital Patiala 
Address  New Academic Building, 1st Floor Department of Community Medicine,GMC Patiala Punjab
New Academic Building, 1st Floor Department of Community Medicine,GMC Patiala Punjab
Patiala
PUNJAB
147001
India 
Phone  7837809884  
Fax    
Email  adsingh44rssb@gmail.com  
 
Source of Monetary or Material Support  
Government medical college and Rajindra Hospital Sangrur Road ,Patiala,Punjab 147001 
 
Primary Sponsor  
Name  AMANDEV SINGH 
Address  Government medical college and Rajindra Hospital Sangrur Road ,Patiala,Punjab 147001 
Type of Sponsor  Other [SELF FUNDED] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
Rohit Batish   New Acaedemic Building Department of Community Medicine 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Aman Dev Singh   Government Medical College and Rajindra Hospital,Patiala,Punjab  Anti Rabies Clinic OPD no -3
Patiala
PUNJAB 
7837809884

adsingh44rssb@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Government Medical College,PATIALA-147001(PUNJAB)INDIA   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: A829||Rabies, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Weigh based rabies immunoglobulin   We will give weight based immunoglobulin in one group and 4 dose anti rabies vaccine and antibody titre estimation on day 14th i.e 7 days after 3rd vaccine.Total period-28 days 
Intervention  Wound only Rabies immunoglobulin  We will give wound only rabies immunoglobulin in one group with 4 dose anti rabies vaccine and estimation of antibody titre on 14th day i.e 7 days after 3rd dose.Total period 28 days 
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  99.00 Year(s)
Gender  Both 
Details  All new cases of animal bites with no prior history of exposure to animal bite and willing to continue treatment from our Centre will be included in study. 
 
ExclusionCriteria 
Details  1) Those patients found reactive to equine immunoglobulin test dose.
2) Individuals with compromised immune systems.(HIV/TB/RA/DM/HCV/others)
3) Pregnant women.
4) Previous documented immunization against rabies.
5) Patients not adhering to ARV schedule as prescribed will be excluded.
6) Referred from other Centre for only RIG infiltration. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Antibody titres via RFFIT on day 14 i.e 7 days after 3rd dose of anti rabies vaccine.  Antibody titres via RFFIT on day 14 i.e 7 days after 3rd dose of anti rabies vaccine. 
 
Secondary Outcome  
Outcome  TimePoints 
Comparison of antibody titre amongst group receiving wound only RIG compared to group receiving weight based RIG.  After receiving antibody titre results 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   26/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Rabies is a 100% fatal yet 100% vaccine preventable disease of central nervous system.Globally and especially in India cases of animal bite are on the rise with an estimated 55000 deaths globally and 20000 alone in India.The high number of deaths can be attributed to lack of awareness about management and seriousness of disease amongst people and also due to non adherence to post exposure prophylaxis which involves 4 dose of anti rabies vaccine with or without RIG over a period of 1 month.
National immunization technical advisory group are advised to review their policies for post exposure prophylaxis and consider adopting intradermal vaccination of shorter duration of 0,3 and 7 as recommended by pasteur institute of cambodia reducing time of schedule from 1 month to 1 week by eliminating 4th dose which is also the most commonly missed dose by patients as advocated by many studies.Also Who in its position paer on Rabies in April 2018 has again advocated for wound only infiltration of RIG/RMAB which not only saves biologicals and patients but is also non inferior to giving any remaining RIG in site distant from site of bite which results in wastage of biologicals.
With above in mind we wish to evaluate -
1) Estimation of Antibody titre on day 14 by RFFIT with weight based RIG in one group and wound based RIG in another.
2) To know socio demographic profile and treatment seeking behaviour amongst these patients.
 
Close